Calcium blockers and coronary risk factors: from the stand point of primary care
Baena Díez, J.M.; Comet Jaumet, D.; Sancho Perpiñán, A.; Oller Colom, M.
Medicina Clinica 109(18): 726-727
1997
ISSN/ISBN: 0025-7753 PMID: 9499151 Document Number: 482511
Document emailed within 1 workday
Related Documents
Van Zwieten, P.A. 1985: Calcium antagonists, calcium entry blockers and calcium overload blockers; nomenclature and classification Nederlands Tijdschrift Voor Geneeskunde 129(17): 777-780Kiani, A.N.; Magder, L.; Petri, M. 2008: Coronary calcium in systemic lupus erythematosus is associated with traditional cardiovascular risk factors, but not with disease activity Journal of Rheumatology 35(7): 1300-1306
Paraskos, J.A. 1986: Cardiovascular pharmacology. III: Atropine, calcium, calcium blockers, and beta-blockers Circulation 74(6 Part 2): Iv86-Iv89
Asanuma, H.; Kitakaze, M. 2004: Calcium channel blockers increasing coronary blood flow via NO-dependent mechanism Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 9): 567-572
Yoshida, K.; Fujii, Y.; Ina, H.; Fujioka, S.; Maseki, T.; Abe, T. 1990: Effects of cardioplegic solution and calcium entry blockers on coronary artery contraction Nihon Kyobu Geka Gakkai 38(1): 86-92
Vermes, I.; Haanen, C.; Fox, C.; Reutelingsperger, C. 1997: Cancer risk in users of calcium channel blockers Hypertension 30(6): 1641-1642
Wilhelmsen, L. 1977: Primary and secondary risk factors for coronary heart disease: their role in prevention Medical Journal of Malaysia 31(4): 296-301
Braun, L.T. 1983: Calcium channel blockers for the treatment of coronary artery spasm: rationale, effects, and nursing responsibilities Heart and Lung: the Journal of Critical Care 12(3): 226-232
Padrini, R.; Piovan, D.; Bova, S.; Moretto, R.; Cargnelli, G.; Ferrari, M. 1987: Physiological, pharmacological and pathological factors affecting the pharmacokinetics of calcium entry blockers Giornale Italiano di Cardiologia 17(9): 786-790
Godfraind, T.; Dessy, C.; Salomone, S. 1992: A comparison of the potency of selective L-calcium channel blockers in human coronary and internal mammary arteries exposed to serotonin Journal of Pharmacology and Experimental Therapeutics 263(1): 112-122
Benet Martí, J.M.; Cortés Vargas, P.; Solé Villa, J.; Guarga Rojas, A.; Marquet Palomer, R.; Muñoz Grimaldo, M.; Pascual Talavera, J.M. 1990: Cardiovascular risk factors. An audit of their detection in primary care Atencion Primaria 7(Special Issue): 20
Fernández, M.I.; Herreros, B.; Bermejo, C.; Bautista, M.; Rojo, M.; Herrera, B. 1996: Prevalence of drinkers at risk and associated factors among men attending primary care clinics Atencion Primaria 17(3): 182-186
Held, P.H.; Yusuf, S. 1993: Effects of beta-blockers and calcium channel blockers in acute myocardial infarction European Heart Journal 14(Suppl): 18-25
Chourashy, B.K. 1988: Anti-anginal drugs: calcium channel blockers, beta-adrenergic blockers and nitrates Journal of the Indian Medical Association 86(10): 274-276
Barretto, A.C.; Wajngarten, M.; Gebara, O.C.; do Serro Azul, J.B.; Pierri, H.; Nussbacher, A.; Pivotto, L.; Bellotti, G.; Pileggi, F. 1996: Risk factors in elderly patients selected by primary care physicians for hypolipemic treatment Arquivos Brasileiros de Cardiologia 67(2): 93-98
Psaty, B.M.; Koepsell, T.D.; Wagner, E.H.; LoGerfo, J.P.; Inui, T.S. 1990: The relative risk of incident coronary heart disease associated with recently stopping the use of beta-blockers JAMA 263(12): 1653-1657
Kido, S.; Ishii, Y.; Hasebe, N.; Ido, A.; Kawashima, E.; Ogawa, Y.; Yamashita, H.; Kikuchi, K.; Onodera, S. 1998: Significance of coronary risk factors and coronary arteriosclerosis for coronary vasospasm Journal of Cardiology 31(3): 135-143
Gardin, J.P.; Patron, P.; Fouqueray, B.; Prigent, A.; Paillard, M. 1988: Maximal PTH secretory rate and set point for calcium in normal subjects and patients with primary hyperparathyroidism. In vivo studies Mineral and Electrolyte Metabolism 14(4): 221-228
Dairo, M.D.; Lawoyin, T.O.; Onadeko, M.O.; Asekun-Olarinmoye, E.O.; Adeniji, A.O. 2005: HIV as an additional risk factors for anaemia in pregnancy: evidence from primary care level in Ibadan, Southwestern Nigeria African Journal of Medicine and Medical Sciences 34(3): 275-279
Chu, K.M.; Boulle, A.M.; Ford, N.; Goemaere, E.; Asselman, V.; Van Cutsem, G. 2010: Nevirapine-associated early hepatotoxicity: incidence, risk factors, and associated mortality in a primary care ART programme in South Africa Plos one 5(2): E9183